NCT04222868 (OneAF) is a clinical trial in Atrial Fibrillation, sponsored by Indonesian Heart Rhythm Society.

Who is sponsoring NCT04222868?

NCT04222868 is sponsored by Indonesian Heart Rhythm Society.

What condition does NCT04222868 study?

NCT04222868 studies Atrial Fibrillation.

Is NCT04222868 still recruiting?

NCT04222868 is currently status unknown. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT04222868: OneAF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Indonesian Registry on Atrial Fibrillation

Status unknown Last updated 18 January 2020

What this trial tests

trial in Atrial Fibrillation in 1,000 participants. Status unknown.

Timeline

1 January 2019

Primary endpoint
30 December 2020

30 December 2021

Quick facts

Lead sponsor	Indonesian Heart Rhythm Society
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 January 2019
Primary completion	30 December 2020
Estimated completion	30 December 2021
Sites	25 locations across Indonesia

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Indonesian Heart Rhythm Society

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our rationale of creation of this registry stems from the fact that the use of VKA in patients with AF is a double-edged sword, physicians face tremendous burden in assigning patients with VKA, due to risk of Bleeding complications despite its potential benefit. We intend to seek a safe and beneficial range of INR on Indonesian patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Indonesian registry on atrial fibrillation (OneAF).
Raharjo SB, Chandranegara AF, Hanafy DA, Yamin M, et al · · 2021 · cited 2× · PMID 34106597 · DOI 10.1097/md.0000000000025725

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04222868 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indonesian Heart Rhythm Society
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04222868.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing